Analysis of cell morphology and immunophenotype detection in 120 patients with myelodysplastic syndrome
Xiaolan Li
Abstract
Xiaolan Li
Abstract
[Objective] To evaluate morphology of the blood and bone marrow cells and surface antigen detection of stem/progenitor and bone marrow cells in the diagnosis and prognosis of patients with myelodysplastic syndrome(MDS).[Methods] The study included 120 MDS cases and 20 cases as control group,which included 13 iron-deficiency anemia cases and 7 thrombocytopenic purpura cases.Blood routine was determined by Sysmex-xe-2100 blood analyzer.Blood and bone marrow smears were dyed by Wright-Giemsa dyeing method.Immunophenotypes were analyzed by flow cytometric using BD FACSCalib.[Results] MDS patients' peripheral blood showed two-line or three-line reduce.Bone marrows' myeloproliferative degree was active and obvious active.Pathological hematopoietic was seen with erythroid and myeloid lines,respectively account for 61.7% and 95.0%.Stem/progenitor cells' expression of antigens(CD34,HLA-DR) and myeloid early antigens(CD33,CD13,CD117) were significantly higher,and gradually heightened with the aggravation of the illness.MDS-RA,RCMD and RAEB type all had significant difference from control group(P0.05).The expression of CD34 in MDS-RAEB-Ⅱ type had presented difference with MDS-RA(P0.05).Myeloid late antigen(CD15) decreased significantly in MDS-RAEB-Ⅱ type(P0.05). [Conclusion] Blood and bone marrow cell morphology combined with immunophenotype detection in MDS patients is helpful for early diagnosis,treatment and prognosis judgment of MDS.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To evaluate morphology of the blood and bone marrow cells and surface antigen detection of stem/progenitor and bone marrow cells in the diagnosis and prognosis of patients with myelodysplastic syndrome(MDS).[Methods] The study included 120 MDS cases and 20 cases as control group,which included 13 iron-deficiency anemia cases and 7 thrombocytopenic purpura cases.Blood routine was determined by Sysmex-xe-2100 blood analyzer.Blood and bone marrow smears were dyed by Wright-Giemsa dyeing method.Immunophenotypes were analyzed by flow cytometric using BD FACSCalib.[Results] MDS patients' peripheral blood showed two-line or three-line reduce.Bone marrows' myeloproliferative degree was active and obvious active.Pathological hematopoietic was seen with erythroid and myeloid lines,respectively account for 61.7% and 95.0%.Stem/progenitor cells' expression of antigens(CD34,HLA-DR) and myeloid early antigens(CD33,CD13,CD117) were significantly higher,and gradually heightened with the aggravation of the illness.MDS-RA,RCMD and RAEB type all had significant difference from control group(P0.05).The expression of CD34 in MDS-RAEB-Ⅱ type had presented difference with MDS-RA(P0.05).Myeloid late antigen(CD15) decreased significantly in MDS-RAEB-Ⅱ type(P0.05). [Conclusion] Blood and bone marrow cell morphology combined with immunophenotype detection in MDS patients is helpful for early diagnosis,treatment and prognosis judgment of MDS.
Key concepts: CD34, Medicine, Immunophenotyping, Bone marrow, Myeloid, Pathology, Antigen, CD117